Adolescent caffeine use, ADHD, and cigarette smoking

Children's Health Care

Volumn 39, Issue 1, 2010, Pages 73-90

  Walker, Leslie R ^a   Abraham, Anisha A ^b   Tercyak, Kenneth P ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; ATTENTION DEFICIT DISORDER; BEVERAGE; CARBONATED BEVERAGE; CHILD BEHAVIOR; CIGARETTE SMOKING; COFFEE; CONTROLLED STUDY; EATING HABIT; FEMALE; FOOD INTAKE; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; RACE DIFFERENCE; SEX DIFFERENCE; SMOKING HABIT; TEA;

EID: 77951185889     PISSN: 02739615     EISSN: None     Source Type: Journal    
DOI: 10.1080/02739610903455186     Document Type: Article

References (59)

1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
2. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.
3. Arbeit, M. L., Nicklas, T. A., Frank, G. C., Webber, L. S., Miner, M. H., & Berenson, G. S. (1988). Caffeine intakes of children from a biracial population: The Bogalusa Heart Study. Journal of the American Dietetic Association, 88, 466-471.
4. August, G. J., Winters, K. C., Realmuto, G. M., Fahnhorst, T., Botzet, A., & Lee, S. (2006). Prospective study of adolescent drug use among community samples of ADHD and non-ADHD participants. Journal of the American Academy of Child & Adolescent Psychiatry, 45, 824-832.
5. Barkley, R. A., & Murphy,K. R. (1998). Attention-deficit hyperactivity disorder: A clinical workbook (2nd ed.) New York: Guilford.
6. Barry, R. J., Clarke, A. R., Johnstone, S. J., Brown, C. R., Bruggemann, J. M., & van Rijbroek, I. (2009). Caffeine effects on resting-state arousal in children. International Journal of Psychophysiology, 73, 355-361.
7. Bernstein, G. A., Carroll, M. E., Thuras, P. D., Cosgrove, K. P., & Roth, M. E. (2002). Caffeine dependence in teenagers. Drug and Alcohol Dependence, 66, 1-6.
8. Bizarro, L., Patel, S., Murtagh, C., & Stolerman, I. P. (2004). Differential effects of psychomotor stimulants on attentional performance in rats: Nicotine, amphetamine, caffeine andmethylphenidate. Behavioural Pharmacology, 15, 195-206.
9. Boeck, C. R., Marques, V. B., Valvassori, S. S., Constantino, L. C., Rosa, D. V., Lima, F. F., et al. (2009). Early long-term exposure with caffeine induces cross-sensitization to methylphenidate with involvement of DARPP-32 in adulthood of rats. Neurochemistry International, 55, 318-322.
10. Brener, N. D., Kann, L., McManus, T., Kinchen, S. A., Sundberg, E. C., & Ross, J. G. (2002). Reliability of the 1999 Youth Risk Behavior Survey questionnaire. Journal of Adolescent Health, 31, 336-342.
11. Center for Science in the Public Interest. (2007). Caffeine content of food and drugs. Washington, DC: Author. Retrieved August 7, 2009, from http://www.cspinet.org/reports/caffeine.pdf
12. Cohen, J., Cohen, P., West, S. G., & Aiken, L. S. (2003). Applied multiple regression/correlation analysis for the behavioral sciences (3rd ed.) Mahwah, NJ: Lawrence Erlbaum Associates, Inc.
13. Congeni, J., & Miller, S. (2002). Supplements and drugs used to enhance athletic performance. Pediatric Clinics of North America, 49, 435-461.
14. Conners, C. K., Levin, E. D., Sparrow, E., Hinton, S. C., Erhardt, D., Meck, W. H., et al. (1996). Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD). Psychopharmacology Bulletin, 32, 67-73.
15. Cruz, N. V., & Bahna, S. L. (2006). Do food or additives cause behavior disorders? Pediatric Annals, 35, 744-754.
16. Dagan, Y., & Doljansky, J. T. (2006). Cognitive performance during sustained wakefulness: A low dose of caffeine is equally effective as modafinil in alleviating the nocturnal decline. Chronobiology International, 23, 973-983.
17. Dager, S. R., & Friedman, S. D. (2000). Brain imaging and the effects of caffeine and nicotine. Annals of Medicine, 32, 592-599.
18. Day, S. (2004, April 4). Business; energy drinks charm the young and caffeinated. The New York Times, p. 34. Retrieved August 7, 2009, from http://query.nytimes.com/gst/fullpage.html?sec= health&res= 9A04EEDC1039F937A35757C0A9629C8B63
19. Dopheide, J. A., & Pliszka, S. R. (2009). Attention-deficit- hyperactivity disorder: An update. Pharmacotherapy, 29, 656-679.
20. Frank, Y., Pergolizzi, R. G., & Perilla, M. J. (2004). Dopamine D4 receptor gene and attention deficit hyperactivity disorder. Pediatric Neurology, 31, 345-348.
21. Frary, C. D., Johnson, R. K., & Wang, M. Q. (2005). Food sources and intakes of caffeine in the diets of persons in the United States. Journal of the American Dietetic Association, 105, 110-113.
22. Gehricke, J. G., Whalen, C. K., Jamner, L. D., Wigal, T. L., & Steinhoff, K. (2006). The reinforcing effects of nicotine and stimulant medication in the everyday lives of adult smokers with ADHD: A preliminary examination. Nicotine & Tobacco Research, 8, 37-47.
23. Gornick, M. C., Addington, A., Shaw, P., Bobb, A. J., Sharp, W., Greenstein, D., et al. (2007). Association of the dopamine receptor D4 (DRD4) gene 7-repeat allele with children with attentiondeficit/ hyperactivity disorder (ADHD): An update. American Journal of Medical Genetics: Part B, Neuropsychiatric Genetics, 144, 379-382.
24. Griffiths, R. R., Juliano, L. M., & Chausmer, A. L. (2003). Caffeine pharmacology and clinical effects. In A. W. Graham, T. K. Schultz, M. F. Mayo-Smith, R. K. Ries, & B. B. Wilford (Eds.), Principles of addiction medicine (3rd ed., pp. 193-224). Chevy Chase, MD: American Society of Addiction Medicine.
25. Griffiths, R. R., & Vernotica, E. M. (2000). Is caffeine a flavoring agent in cola soft drinks? Archives of Family Medicine, 9, 727-734.
26. Gross, M. D. (1975). Caffeine in the treatment of children with minimal brain dysfunction or hyperkinetic syndrome. Psychosomatics, 16, 26-27.
27. Health Canada. (2007). It's your health: Caffeine. Ottawa: Author. Retrieved August 7, 2009, from http://www.hc-sc.gc.ca/hl-vs/iyh-vsv/food- aliment/caffeine-eng.php
28. Hennessy, S., Bilker, W. B., Berlin, J. A., & Strom, B. L. (1999). Factors influencing the optimal control-to-case ratio in matched case-control studies. American Journal of Epidemiology, 149, 195-197.
29. Hertz, J. A., & Knight, J. R. (2006). Prescription drug misuse: A growing national problem. Adolescent Medicine Clinics, 17, 751-769.
30. Istvan, J., & Matarazzo, J. D. (1984). Tobacco, alcohol, and caffeine use: A review of their interrelationships. Psychological Bulletin, 95, 301-326.
31. Juliano, L. M., & Griffiths, R. R. (2004). A critical review of caffeine withdrawal: Empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology, 176, 1-29.
32. Klesges, R. C., Ray, J. W., & Klesges, L. M. (1994). Caffeinated coffee and tea intake and its relationship to cigarette smoking: An analysis of the Second National Health and Nutrition Examination Survey (NHANES II). Journal of Substance Abuse, 6, 407-418.
33. Krieger, N., Chen, J. T., Waterman, P. D., Soobader, M. J., Subramanian, S. V., & Carson, R. (2003). Choosing area based socioeconomic measures to monitor social inequalities in low birth weight and childhood lead poisoning: The Public Health Disparities Geocoding Project (US). Journal of Epidemiology and Community Health, 57, 186-199.
34. Kuntsi, J., McLoughlin, G., & Asherson, P. (2006). Attention deficit hyperactivity disorder. Neuromolecular Medicine, 8, 461-484.
35. Linnet, K. M., Dalsgaard, S., Obel, C., Wisborg, K., Henriksen, T. B., Rodriguez, A., et al. (2003). Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence. American Journal of Psychiatry, 160, 1028-1040.
36. Lynch, B. S., & Bonnie, R. J. (1994). Growing up tobacco free: Preventing nicotine addiction in children and youths. Washington, DC: National Academy Press.
37. Martin, C. A., Cook, C., Woodring, J. H., Burkhardt, G., Guenthner, G., Omar, H. A., et al. (2008). Caffeine use: Association with nicotine use, aggression, and other psychopathology in psychiatric and pediatric outpatient adolescents. The Scientific World Journal, 8, 512-516.
38. Mason, M. J., Walker, L. R., Wine, L. A., Knoper, T. S., & Tercyak, K. P. (2007). Child and adolescent tobacco and substance use within the context of ADHD: Implications for prevention and treatment. Journal of Clinical Psychology in Medical Settings, 14, 227-237.
39. McCarthy, D. M., Mycyk,M. B., & DesLauriers, C. A. (2008). Hospitalization for caffeine abuse is associated with abuse of other pharmaceutical products. American Journal of EmergencyMedicine, 26, 799-802.
40. Nehlig, A., Daval, J. L., & Debry, G. (1992). Caffeine and the central nervous system:Mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Research Reviews, 17, 139-170.
41. Oberstar, J. V., Bernstein, G. A., & Thuras, P. D. (2002). Caffeine use and dependence in adolescents: One-year follow-up. Journal of Child and Adolescent Psychopharmacology, 12, 127-135.
42. O'Dea, J. A. (2003). Consumption of nutritional supplements among adolescents: Usage and perceived benefits. Health Education Research, 18, 98-107.
43. Pendergrast, M. (1999). Uncommon grounds: The history of coffee and how it transformed our world. New York: Basic Books.
44. Pires, V. A., Pamplona, F. A., Pandolfo, P., Fernandes, D., Prediger, R. D., & Takahashi, R. N. (2009). Adenosine receptor antagonists improve short-term object-recognition ability of spontaneously hypertensive rats: A rodent model of attention-deficit hyperactivity disorder. Behavioural Pharmacology, 20, 134-145.
45. Pollak, C. P., & Bright, D. (2003). Caffeine consumption and weekly sleep patterns in US seventh-, eighth-, and ninth-graders. Pediatrics, 111, 42-46.
46. Prince, J. B. (2006). Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: Update on new stimulant preparations, atomoxetine, and novel treatments. Child and Adolescent Psychiatric Clinics of North America, 15, 13-50.
47. Reissig, C. J., Strain, E. C., & Griffiths, R. R. (2009). Caffeinated energy drinks-A growing problem. Drug and Alcohol Dependence, 99, 1-10.
48. Rogers, J. L., De Santis, S., & See, R. E. (2008). Extended methamphetamine self-administration enhances reinstatement of drug seeking and impairs novel object recognition in rats. Psychopharmacology (Berlin), 199, 615-624.
49. Scheffer, R. E. (2006). Psychopharmacology:Clinical implications of brain neurochemistry. Pediatric Clinics of North America, 53, 767-775.
50. Schnackenberg, R. C. (1973). Caffeine as a substitute for Schedule II stimulants in hyperkinetic children. American Journal of Psychiatry, 130, 796-798.
51. Shute, N. (2007). Over the limit? Americans young and old crave high-octane fuel, and doctors are jittery. US News and World Report, 142, 60-68.
52. Sin, D. D., Svenson, L. W., & Man, S. F. (2001). Do area-based markers of poverty accurately measure personal poverty? Canadian Journal of Public Health, 92, 184-187.
53. Temple, J. L. (2009). Caffeine use in children: What we know, what we have left to learn, and why we should worry. Neuroscience and Biobehavioral Reviews, 33, 793-806.
54. Tercyak, K. P., & Audrain-McGovern, J. (2003). Personality differences associated with smoking experimentation among adolescents with and without comorbid symptoms of ADHD. Substance Use & Misuse, 38, 1953-1970.
55. Tercyak, K. P., Lerman, C., & Audrain, J. (2002). Association of attention-deficit/hyperactivity disorder symptoms with levels of cigarette smoking in a community sample of adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 799-805.
56. Wammanda, R. D. (2007). Hyperactivity and inattention-A successful response to table coffee. Nigerian Journal of Clinical Practice, 10, 182-183.
57. Wilens, T. E., & Biederman, J. (2006). Alcohol, drugs, and attention-deficit/hyperactivity disorder: A model for the study of addictions in youth. Journal of Psychopharmacology (Oxford, England), 20, 580-588.
58. World Health Organization. (1992). The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. Geneva: Author.
59. Young, R., Gabryszuk, M., & Glennon, R. A. (1998). ()Ephedrine and caffeine mutually potentiate one another's amphetamine-like stimulus effects. Pharmacology, Biochemistry, and Behavior, 61, 169-173.